# Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

> **NCT02484573** · NA · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 39 (estimated)

## Conditions studied

- Liver Cirrhoses

## Interventions

- **DRUG:** Propanolol

## Key facts

- **NCT ID:** NCT02484573
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2020-01
- **Final completion:** 2020-08
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484573, "Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02484573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*